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during the vasculature development will provide insights into
the molecular mechanism for the establishment of arterial-
venous identity.
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We have successfully induced the formation of 20 different
organs in vitro from animal caps (undifferentiated or multipo-
tent cells) of Xenopus blastulae and six different tissues from
mice embryonic stem cells. For the Xenopus embryo, we subse-
quently have attempted to transplant these in vitro–generated
organs into embryos to determine their functional capacity. In
the experiment we induced the pronephros (nephron) consist-
ing of renal tubule, glomerulus, and renal duct from animal caps
treated with activin and retinoic acid. Then we transplanted
these cell mass treated with activin and retinoic acid into an
embryo in which the renal rudiment had been removed. We
found that the transplant developed into pronephros normally
and function in vivo. Using this system, we have cloned and
analyzed the pronephros-specific genes in Xenopus develop-
ment. Sequential gene expressions of pronephros in vivo and in
vitro resemble the mesonephros formation in mammals. In the
screening for genes expressed in pronephroi, we isolated a novel
gene, named dullard. Dullard protein contains the C-terminal
conserved domain of nuclear LIM interactor-interacting fac-
tor (NLI-IF), a protein whose function is unknown. The spa-
tial expression was in neural regions at neurula stages, and
localized to neural tissues, branchial arches, and pronephroi.
The translational knockdown of dullard resulted in failure of
neural tube development and structural deformation of the
pronephric tubules, and the embryos consequently showed a re-
duction of head development. In the same screening method for
the pronephros-specific genes, we isolated the XTRAP-gamma
gene that codes translucent-associated protein, one of the sub-
unit of the translocon-associated protein complex. XTRAP is
one of the proteins proposed to aid in the translocation of
nascent polypeptides into the lumen of the endothelium retic-
ulum. XTRAP-gamma is expressed in pronephros tubules dur-
ing pronephros development. The translational knockdown of
XTRAP-gamma caused the suppression of tubulogenesis, the
increase of Xlim-1 expression, and the decrease of Xpax-2 and
Xwnt-4 expression. This translational knockdown of XTRAP-
gamma also inhibited differentiation of the pronephros in ani-
mal caps by the treatment with activin and retinoic acid. These
results showed that XTRAP-gamma plays an important role in
the pronephric development. As another approach to clarify the
molecular mechanisms of renal development, we investigated
the role of Xenopus frizzled-8 (Xfz8) in pronephros develop-
ment to study the relation between Wnt signaling and nephric
development. Translational inhibition of Xfz8 caused reduc-
tion in the staining of a duct-specific antibody and defects in
pronephric tubule branching, while there was no effect on the
expression of early pronephric maker genes in the duct region.
Histologic analysis showed that the Xfz8-inhibited cells failed
to form a normal epithelial structure. These results suggest that
Xfz8 is involved in the formation of epithelium in the develop-
ing pronephric duct and tubules.
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Matrix metalloproteinase-9 (MMP-9) has a restricted pattern
of expression in developmental and adult tissues. Its principal
substrate is type IV collagen but it can degrade other base-
ment membrane molecules, as well as substrates that are not
matrix components. We have previously shown that MMP-9 is
produced at the first stage of kidney embryogenesis in vivo and
is required for branching morphogenesis in vitro [Lelongt B,
Trugnan G, Murphy G, Ronco PM: Matrix metalloproteinases
MMP2 and MMP9 are produced in early stages of kidney mor-
phogenesis but only MMP9 is required for renal organogene-
sis in vitro. J Cell Biol 137:1–11, 1997]. We took advantage of
the availability of MMP-9–deficient mice to analyze their re-
nal phenotype under physiologic condition and in a model of
acute renal failure. MMP-9–deficient mice are actually viable,
suggesting the absence of major kidney defects. However, we
did observe two renal abnormalities. First, MMP-9–deficient
adult mice have a 15% reduction of nephron number that most
likely results from subtle defects of branching morphogenesis
and a marked increase in mesenchymal apoptosis. Second, 12-
month-old deficient mice develop renal impairment and atro-
phy compared to control mice. This is most likely explained by
superimposition on nephron loss of histologic lesions character-
ized by an increased interstitial deposition of extracellular ma-
trix associated with inflammatory cell infiltration as compared
to control kidneys. This mild, but highly significant phenotype,
is in the same order of magnitude as the one observed in long
bones [Vu TH, Shipley JM, Bergers G, et al: MMP-9/gelatinase
B is a key regulator of growth plate angiogenesis and apoptosis
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of hypertrophic chondrocytes. Cell 93:411–422, 1998]. We then
asked whether the antiapoptotic role of MMP-9 observed dur-
ing renal development could extend to renal pathology. Since
there is no renal alteration in 3-month-old MMP-9–deficient
mice, we used those mice and control mice to induce an acute re-
nal failure by intraperitoneal injection of folic acid. This model is
characterized by an apoptotic phase 12 to 24 hours after the folic
acid injection [Ortiz A, Lorz C, Catalan MP, et al: Expression of
apoptosis regulatory proteins in tubular epithelium stressed in
culture or following acute renal failure. Kidney Int 57:969–981,
2000]. Therefore, we compared kidneys from MMP-9–deficient
mice and control mice 18 hours after folic acid injection. Both
groups of mice developed renal failure of equal severity. MMP-
9 activity was markedly increased in control mice, suggesting an
effect of this enzyme. Indeed, renal lesions were more severe in
MMP-9–deficient mice in which the number of dilated tubules
was increased and the number of apoptotic cell was raised by
two- to threefold in cortex, medulla, and papilla. In summary,
MMP-9–deficient mice exhibit increased extent of apoptosis in
the folic acid model of acute renal failure as well as in kidney
development. We are currently investigating the MMP-9 anti-
apoptotic mode of action.
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The glial cell line–derived neurotrophic factor (GDNF)/
rearrangement during transfection, tyrosine kinase (RET) sig-
naling is recognized as a critical pathway of renal branching mor-
phogenesis, and much attention has been paid to the molecules
that function upstream of this pathway. It was suggested that
transcription factors, Pax2 and Eya-1, are responsible for Gdnf
expression, and Foxc1 prevents ectopic ureteric budding from
Wolffian duct by repressing Gdnf and Eya1. In addition, vitamin
A signal from stromal mesenchyme is necessary for Ret expres-
sion. Recently it was reported that Wnt11 and Sprouty proteins
are associated with the GDNF/RET signaling, but the detailed
process downstream of the GDNF/RET signaling in renal de-
velopment is still poorly understood. We performed an exhaus-
tive analysis of GDNF-inducible genes by differential display
to identify an important molecule which function downstream
of the GDNF/RET signaling pathway. As a consequence, we
found the increased expression of 14 genes by GDNF. Among
them, we focused on a new gene with a BTB/POZ domain and
C2H2-type zinc finger motifs that was named GZF1 (GDNF-
inducible zinc finger gene 1). To elucidate the importance of
GZF1 on kidney development, we stained the mouse embry-
onic kidney with anti-GZF1 antibody. Interestingly, the ureteric
bud epithelia of embryonic metanephroi were strongly stained,
whereas S-shaped or comma-shaped bodies were not stained.
Using serial sections, we detected the expression of GZF1 and
RET in the same ureteric buds. Furthermore, antisense oligonu-
cleotides (ODNs) of the Gzf1 markedly impaired the ureteric
bud branching in the metanephric organ culture, suggesting that
the induction of GZF1 via the GDNF/RET signaling system is
required for renal branching morphogenesis. We investigated
the transcriptional activity of GZF1 by luciferase reporter gene
assay. In this assay, it was revealed that the GZF1 possesses tran-
scriptional repressive activity. To examine the binding sequence
for GZF1, we employed cyclic amplification and selection of
targets (CASTing). Finally, a consensus sequence was derived
from the sequence alignment of individual clones. We named it
GZF1 recognition element (GRE). Next we searched for po-
tential target genes that might be regulated by GZF1 and found
that a variety of genes possess the GRE in their 5’ upstream reg-
ulatory region. We are now investigating the effect of the GRE
on the promoter activity of one gene among them. To examine
whether the GZF1 binds the promoter region of this gene, we
performed modified chromatin immunoprecipitation assay. It
was shown that GZF1 binds the promoter region of this gene.
Further analysis about the transcriptional effect of GZF1 on this
gene is now moving. As described above, this novel gene GZF1
may play a crucial role in renal development regulated by the
GDNF/RET signaling. We are now generating Gzf1−/− mouse.
We expect this novel molecule will promote our understanding
of the mechanisms of the renal organogenesis. Furthermore, its
clinical application to the treatment of renal disease, especially
to the regeneration of the kidney, should be explored in the
future.
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